Kyoung Mi Eun

Kyoung Mi Eun

Auto-generated profile, based on publicly available information

Kyoung Mi Eun

Department of Otorhinolaryngology-Head and Neck Surgery, Boramae Medical Center, Seoul National University College of Medicine, Seoul, Korea

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in Allergy, Asthma & Immunology Research
Verified
Journal Article
Open access
PDF file
DKDong-Kyu Kim
Dong-Kyu Kim
KEKyoung Mi Eun
Kyoung Mi Eun
MKMin-Kyung Kim
Min-Kyung Kim
DCDeuktae Cho
Deuktae Cho
SHSun A Han
Sun A Han
DKDae Woo Kim
Dae Woo Kim
Kim DK, et al. Allergy Asthma Immunol Res. 2019 Mar;11(2):201-211. https://doi.org/10.4168/aair.2019.11.2.201

1 January 2020 in Allergy, Asthma & Immunology Research
Verified
Journal Article
Open access
DKDong-Kyu Kim
Dong-Kyu Kim
JKJin Youp Kim
Jin Youp Kim
YHYoung Eun Han
Young Eun Han
JKJoon Kon Kim
Joon Kon Kim
HLHee-Suk Lim
Hee-Suk Lim
DKDae Woo Kim
Dae Woo Kim
Various immune cells, including eosinophils and neutrophils, are known to contribute to the development of chronic rhinosinusitis with nasal polyps (CRSwNP). However, the current understanding of the role of neutrophils in the development of CRSwNP still remains unclear. Therefore, we investigated risk factors for refractoriness of CRSwNP in an Asian population. Protein levels of 17 neutrophil-related mediators in nasal polyps (NPs) were determined by multiplex immunoassay, and exploratory factor analysis using principal component analysis was performed. Immunofluorescence analysis was conducted to detect human neutrophil elastase (HNE) or myeloperoxidase (MPO)-positive cells. Tissue eosinophilic nasal polyp (ENP) and tissue neutrophilia (Neuhigh) were defined as greater than 70 eosinophils and 20 HNE-positive cells, otherwise was classified into non-eosinophilic nasal polyp (NENP) and absence of tissue neutrophilia (Neulow). In terms of disease control status, NENP-Neulow patients showed the higher rate of disease control than NENP-Neuhigh and ENP-Neuhigh patients. Linear by linear association demonstrated the trend in refractoriness from NENP-Neulow to NENP-Neuhigh or ENP-Neulow to ENP-Neuhigh. When multiple logistic regression was performed, tissue neutrophilia (hazard ratio, 4.38; 95% confidence interval, 1.76-10.85) was found as the strongest risk factor for CRSwNP refractoriness. Additionally, exploratory factor analysis revealed that interleukin (IL)-18, interferon-γ, IL-1Ra, tumor necrosis factor-α, oncostatin M, and MPO were associated with good disease control status, whereas IL-36α and IL-1α were associated with refractory disease control status. In subgroup analysis, HNE-positive cells and IL-36α were significantly upregulated in the refractory group (P = 0.0132 and P = 0.0395, respectively), whereas MPO and IL-18 showed higher expression in the controlled group (P = 0.0002 and P = 0.0009, respectively). Moreover, immunofluorescence analysis revealed that IL-36R⁺HNE⁺-double positive cells were significantly increased in the refractory group compared to the control group. We also found that the ratio of HNE-positive cells to α1 anti-trypsin was increased in the refractory group. Tissue neutrophilia had an influence on treatment outcomes in the Asian CRSwNP patients. HNE-positive cells and IL-36α may be biomarkers for predicting refractoriness in Asians with CRSwNP. Additionally, imbalances in HNE and α1 anti-trypsin may be associated with pathophysiology of neutrophilic chronic rhinosinusitis.

1 January 2019 in Allergy, Asthma & Immunology Research
Verified
Journal Article
Open access
GRGwanghui Ryu
Gwanghui Ryu
DKDong-Kyu Kim
Dong-Kyu Kim
HDHun-Jong Dhong
Hun-Jong Dhong
KEKyoung Mi Eun
Kyoung Mi Eun
KLKyung Eun Lee
Kyung Eun Lee
DKDae Woo Kim
Dae Woo Kim
Despite medical and surgical treatments, some cases of nasal polyps (NP) exhibit recidivism. However, the endotype of refractory chronic rhinosinusitis with NP (CRSwNP) remains unclear. Therefore, the objective of this study was to characterize the immunological profile of refractory CRSwNP. The control (n =23), primary NP group (pNP, n =70) and refractory NP group (rNP, n =86) were enrolled in this study. Patients who underwent revision surgeries due to failed maximal medical treatment after primary surgery were defined as the rNP group. A total of 18 inflammatory markers were investigated in nasal tissues using multiplex cytokine assay or enzyme-linked immunosorbent assay. The clinical characteristics of rNP included more extensive disease and worse clinical course after surgery. Additionally, rNP subjects showed higher infection rate (mucopurulence and culture-positive rate), more frequent use of antibiotics and suffered from symptomatic bacterial infection, increased asthma morbidity compared to pNP. Cytokine profile analysis showed that levels of Th17-associated mediators (myeloperoxidase, interleukin (IL)-8, IL-17A and IL-23), B-cell activating factor (BAFF) and Th1 cytokine (interferon-γ) were up-regulated in rNP compared to controls and pNP. Human neutrophil elastase-positive cells were also enhanced in rNP compared with pNP. Upregulation of Th17/Th1mediators and BAFF were observed in rNP, regardless of tissue eosinophilia or asthmatic comorbidity. Interestingly, eosinophilic markers, such as eosinophil cationic protein and C-C motif chemokine ligand 24, were up-regulated in asthmatic rNP compared to pNP and controls. Levels of anti-dsDNA immunoglobulin (Ig) G and IgA were up-regulated in rNP and highest in asthmatic eosinophilic rNP among subtypes of rNP. Our results suggest that Th17/Th1-associated mediators and BAFF may play a role and be a potential therapeutic target in refractory CRSwNP. Additionally, eosinophilic markers and autoantibodies may contribute to refractoriness in asthmatic rNP.

1 January 2020 in Allergy, Asthma & Immunology Research
Verified
Journal Article
Open access
PDF file
DKDong-Kyu Kim
Dong-Kyu Kim
AJAra Jo
Ara Jo
HLHee-Suk Lim
Hee-Suk Lim
JKJin Youp Kim
Jin Youp Kim
KEKyoung Mi Eun
Kyoung Mi Eun
DKDae Woo Kim
Dae Woo Kim
Kim DK, et al. Allergy Asthma Immunol Res. 2020 Nov;12(6):980-993. https://doi.org/10.4168/aair.2020.12.6.980

1 January 2024 in Allergy, Asthma & Immunology Research
Verified
Journal Article
Open access
PDF file
AJAra Jo
Ara Jo
HLHee-Suk Lim
Hee-Suk Lim
KEKyoung Mi Eun
Kyoung Mi Eun
JPJin-A Park
Jin-A Park
SHSeung-No Hong
Seung-No Hong
DKDae Woo Kim
Dae Woo Kim
Jo A, et al. Allergy Asthma Immunol Res. 2024 Sep;16(5):473-489. https://doi.org/10.4168/aair.2024.16.5.473

1 February 2018 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Open access
DKDae Woo Kim
Dae Woo Kim
DKDong-Kyu Kim
Dong-Kyu Kim
IKIL GYU KONG
IL GYU KONG
KEKyoung Mi Eun
Kyoung Mi Eun
TCThomas B Casale
Thomas B Casale
SCSeong Ho Cho
Seong Ho Cho